A possible role for saliva as a diagnostic fluid in patients with chronic pain

Seminars in Arthritis and Rheumatism

Volumn 27, Issue 6, 1998, Pages 348-359

  Fischer, H P ^a   Eich, W ^a   Russell, I J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Calcitonin gene related peptide (CGRP); Chronic pain; Fibromyalgia syndrome (FMS); Nerve growth factor (NGF); Saliva; Serotonin (5HT); Substance P (SP)

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROPEPTIDE Y; SALIVA PROTEIN; SEROTONIN;

CHRONIC PAIN; CLUSTER HEADACHE; FIBROMYALGIA; HUMAN; LABORATORY TEST; MIGRAINE; NOCICEPTION; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SALIVA ANALYSIS; TENSION HEADACHE;

EID: 0031861715     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(98)80014-0     Document Type: Article

References (153)

1. Fox P.C. van der Ven P.F. Sonies B.C. Weiffenbach J.M. Baum B.J. Xerostomia: evaluation of a symptom with increasing significance J Am Dent Assoc 110 1985 519 525
2. Mandel I.D. The role of saliva in maintaining oral homeostasis J Am Dent Assoc 119 1989 298 304
3. Schenkels L.C.P.M. Veerman E.C.I. Amerongen A.V.N. Biochemical composition of human saliva in relation to other mucosal fluids Crit Rev Oral Biol Med 6 1995 161 175
4. Barka T. Biologically active polypeptides in submandibular glands J Histochem Cytochem 28 1980 836 859
5. Mathison R. Davison J.S. Befus A.D. Neuroendocrine regulation of inflammation and tissue repair by submandibular gland factors Immunol Today 15 1994 527 532
6. Sabbadini E. Berczi I. The submandibular gland: a key organ in the neuro-immuno-regulatory network? Neuroimmunomodulation 2 1995 184 202
7. Levine J.D. Goetzl E.J. Basbaum A.I. Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides Rheum Dis Clin North Am 13 1987 369 383
8. Menkes C.J. Renoux M. Laoussadi S. Mauborgne A. Bruxelle J. Cesselin F. Sustance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis J Rheumatol 20 1993 714 717
9. Fortier L.A. Nixon A.J. Distributional changes in substance P nociceptive fiber patterns in naturally osteoarthritic articulations J Rheumatol 24 1997 524 530
10. Pritchett J.W. Substance P level in synovial fluid may predict pain relief after knee replacement J Bone Joint Surg Br 79 1997 114 116
11. Russell I.J. Neurochemical pathogenesis of fibromyalgia syndrome J Musculoskeletal Pain 4 1996 61 92
12. Aguirre A. Testa-Weintraub L.A. Banderas J.A. Haraszthy G.G. Reddy M.S. Levine M.J. Sialochemistry: a diagnostic tool? Crit Rev Oral Biol Med 4 1993 343 350
13. Penschow J.D. Coghlan J.P. Secretion of glandular kallikrein and renin from the basolateral pole of mouse submandibular duct cells: an immunocytochemical study J Histochem Cytochem 41 1993 95 103
14. Pikula D.L. Harris E.F. Desiderio D.M. Fridland G.H. Lovelace J.L. Methionine enkephalin-like, substance P-like and beta-endorphin-like immunoreactivity in human parotid saliva Arch Oral Biol 37 1992 705 709
15. Takeyama M. Mori K. Takayama F. Kondo K. Kitagawa K. Fudji N. Enzyme immunoassay of a substance P-like immunoreactive substance in human plasma and saliva Chem Pharm Bull 38 1990 3494 3496
16. Konttinen Y.T. Hukkanen M. Kemppinen P. Segerberg M. Sorsa T. Malmström M. Peptide-containing nerves in labial salivary glands in Sjögren's syndrome Arthritis Rheum 35 1992 815 820
17. Hoffman H. McAuslan B. Robertson D. Burnett E. An endothelial growth-stimulating factor from salivary glands Exp Cell Res 102 1976 269 275
18. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal J Biol Chem 237 1962 1555 1558
19. Jones R.O. The in vitro effect of epithelial growth factor on rat organ cultures Exp Cell Res 43 1966 645 656
20. Tepperman F.S. Jarvis A. Hirst M. Detection of enkephalinlike immunoreactive material in human saliva Prog Neuro-Psychopharmacol Biol Psychiatry 12 1988 285 289
21. van Setten G.B. Basic fibroblast growth factor in human saliva: detection and physiological implications Laryngoscope 105 1995 610 612
22. Hansson H.-A. Tunhall S. Epidermal growth factor and insulin-like growth factor I are localized in different compartments of salivary gland duct cells: Immunohistochernicalevidence Acta Physiol Scand 134 1988 383 389
23. Kerr M. Lee A. Wang P.-L. Purushotham K.R. Chegini N. Yamamoto H. Detection of insulin, insulin-like growth factors I and II in saliva and potential synthesis in the salivary glands of mice Biochem Pharmacol 49 1995 1521 1531
24. Attardi D.G. Schlesinger M.J. Schlesinger S. Submaxillary gland of mouse: properties of a purified protein affecting muscle tissues in vitro Science 156 1967 1253 1255
25. Cohen S. Purification of a nerve growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum Proc Natl Acad Sci U S A 46 1960 302 311
26. Adler R. Narbaitz R. Action of rat submaxillary gland extracts on neural tube growth in organ culture J Embryol Exp Morphol 14 1965 281 287
27. Naukam R.J. Parris W.C.V. Kambam J.R. Kruskal J.B. The effects of neurokinin A, neurokinin B and eledoisin on substance P analysis J Clin Monit 7 1991 181 185
28. Parris W.C.V. Kambam J.R. Naukam R.J. Rama Sastry B.V. Immunoreactive substance P is decreased in saliva of patients with chronic back pain syndromes Anesth Analg 70 1990 63 67
29. Yeh Y.-C. Guh J.-Y. Yeh H. Yeh H.-W. Transforming growth factor type alpha in normal human adult saliva Mol Cell Endocrinol 67 1989 246 255
30. Miller D.A. Lee A. Pelton R.W. Chen E.Y. Moses H.L. Derynck E.Y. Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos Mol Endocrinol 3 1989 1108 1114
31. Miller D.A. Pelton R.W. Derynck R. Moses H.L. Transforming growth factor-beta: a family of growth regulatory peptides Ann N Y Acad Sci 593 1990 208 217
32. Mogi M. Matsuura S. Suzuki K. Differential expression of transforming growth factor-alpha and epidermal growth factor during postnatal development of rat submandibular gland Biochem Biophys Res Commun 217 1995 271 277
33. (suppl) Lundberg J.M. Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands Acta Physiol Scand 112 1981 1 57
34. Nicolodi M. Del Bianco E. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache Cephalgia 10 1990 39 50
35. Edwards A.V. Tobin G. Ekstrom J. Bloom S.R. Nitric oxide and release of the peptide VIP from parasympathetic terminals in the submandibular gland of the anaesthetized cat Exp Physiol 81 1996 349 359
36. Hutson J.M. Niall M. Evans D. Fowler R. Effect of salivary glands on wound contraction in mice Nature 279 1979 793 795
37. Sheridan J.W. Stanley E.R. Tissue sources of bone marrow colony-stimulating factor J Cell Physiol 78 1971 451 460
38. Shimizu M. Sato J. Ishii T. Kanada T. Shinoda M. Androgen-induced production of colony-stimulating factor (CSF) and colony-inhibitory factor (CIF) in the submandibular gland in female mice J Pharmacobiodyn 12 1989 352 356
39. Fava-de-Moraes F. Zangheri E.O. Doine A.I. Immunohistochemical localization of erythropoietin in the rat and mouse submandibular gland Histochem J 11 1979 97 102
40. Angeletti P.U. Salvi M.L. Capani F. Frati L. Granulocytosisinducing factor from the mouse submaxillary gland Biochim Biophys Acta 111 1965 344 346
41. Takeda Y. Yamasaki Y. Yamabe H. Suzuki Y. Haebara H. Atrophy of the lymphoid tissues of mice induced by extracts of the submaxillary gland Proc Soc Exp Biol Med 126 1967 212 216
42. Ito S. Yamaguchi K. Kusumoto Y. Hama H. Shibata A. Angiotensin-like immunoreactivity in the rat submaxillary gland Arch Histol Jpn 42 1979 89 93
43. Partlow L.M. Wallace L.J. Wardell L.J. NGF and an and complimentary protease in mouse saliva elicited by nerve stimulation J Physiol Lond 310 1981 1 11
44. Takeuchi T. Takemoto T. Tan T. Miwa T. Gastrin-like immunoreactivity in salivary gland and saliva Lancet 2 1973 920
45. Lawrence A.M. Tan S. Hojvat S. Kirsteins L. Salivary gland hyperglycemic factor: an extrapancreatic source of glucagon-like material Science 195 4273 1977 70 72
46. Liske R. Reber K. Nonsuppressible insulin-like activity in rat organs as detected by fluorescent antibody and radioimmunoassay techniques Horm Res 7 1976 214 217
47. Hoshino K. Lin C.D. Lethal factor released from submandibular grafts in mice Can J Physiol Pharmacol 47 1969 329 334
48. Trautsehold I. Werle E. Schmal A. Hendrikoff N.G. The hormonal influence of the isorenin level of the submandibular gland of white mice and on the localization of the enzyme in the gland Hoppe Seylers Z Physiol Chem 344 1966 232 243
49. Sharma H.S. Nyberg F. Olsson Y. Dey P.K. Alteration of substance P after trauma to the spinal cord: an experimental study in the rat Neuroscience 38 1990 205 212
50. Malmberg A. Yaksh T.L. Hyperalgesia mediated by spinal glutamate or substance Preceptor blocked by spinal cyclooxygenase inhibition Science 257 1992 1276 1279
51. Schwab W. Bilgicyildirim A. Funk R.H. Microtopography of the autonomic nerves in the rat knee: a fluorescence microscopic study Anat Rec 247 1997 109 118
52. Marshall K.W. Chiu B. Inman R.D. Substance P and arthritis: analysis of plasma and synovial fluid levels Arthritis Rheum 33 1990 87 90
53. Lotz M. Carson D.A. Vaughan J.H. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis Science 235 1987 893 895
54. Levine J.D. Collier D.H. Basbaum A.I. Moskowitz M.A. Helms C.A. Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis J Rheumatol 12 1985 406 411
55. Jorgensen C. Sany J. Modulation of the immune response by the neuro-endocrine axis in rheumatoid arthritis Clin Exp Rheumatol 12 1994 435 441
56. Vaeroy H. Helle R. Forre O. Kass E. Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia Pain 32 1988 21 26
57. Russell I.J. Orr M.D. Littman B. Vipraio G.A. Alboukrek D. Michalek J.E. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome Arthritis Rheum 37 1994 1593 1601
58. (abstr) Welin M. Bragee B. Nyberg F. Kristiansson M. Elevated substance P levels are contrasted by a decrease in metenlcephalinarg-phe levels in CSF from fibromyalgia patients J Musculoskeletal Pain 3 Suppl 1 1995 4
59. Mountz J.M. Bradley L.A. Modell J.G. Alexander R.W. Triana-Alexander M. Aaron L.A. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain thresholdlevels Arthritis Rheum 38 1995 926 938
60. Marukawa H. Shimomura T. Takahashi K. Salivary substance P, 5-Hydroxytryptamine and gamma-aminobutyric acid levels in migraine and tension-type headache Headache 36 1996 100 104
61. Dalby P.L. Ramanathan S. Ruudy T.E. Roy L. Amenta J.S. Aber A. Plasma and saliva substance P levels: the effects of acute pain in pregnant and non-pregnant women Pain 69 1997 263 267
62. Nicolodi M. Nostril capsaicin application as a model of trigeminal primary sensory neuronal activation Cephalgia 14 1994 134 138
63. Sicuteri F. Fanciullacci M. Nicolodi M. Geppetti P. Fusco B.M. Marabini S. Substance P theory: a unique focus on the painful and painless phenomena of cluster headache Headache 30 1990 69 79
64. Tamatani M. Senba E. Tohyama M. Calcitonin generelated peptide- and substance P-containing primary afferent fibers in the dorsal column of the rat Brain Res 495 1989 122 130
65. Hernanz A. DeMiguel E. Romera N. Perez-Ayala C. Gijon J. Arnalich F. Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease Br J Rheumatol 32 1993 31 35
66. Harper G.P. Thoenen H. Nerve growth factor: biological significance, measurement and distribution J Neurochem 34 1980 5 16
67. Richardson P.M. Ebendal T. Nerve growth activity in rat peripheral nerve Brain Res 246 1982 57 64
68. Vantini G. Schiavo N. DiMartino A. Polato P. Triban C. Callegaro L. Evidence for a physiological role of nerve growth factor in the central nervous system of neonatal rats Neuron 3 1989 267 273
69. Mattson M.P. Cheng B. Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis Stroke 24 1993 I136 I140
70. discussion Mattson M.P. Cheng B. Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis Stroke 24 suppl 12 1993 I144 I145
71. Lewin G.R. Rueff A. Mendell L.M. Peripheral and central mechanisms of NGF-induced hyperalgesia Eur J Neurosci 6 1994 1903 1912
72. Amann R. Schuligoi R. Herzeg G. Donnerer J. Intraplantar injection of NGF into the rat hind paw: local edema and effects on thermal nociceptive threshold Pain 64 1996 323 329
73. McMahon S.B. NGF as a mediator of inflammatory pain Philos Trans R Soc Load B Biol Sci 351 1996 431 440
74. Anand P. NGF regulates nociception in human health and disease Br J Anaesth 75 1995 201 208
75. Petty B.G. Corrnblath D.R. Adornato B.T. Chaundhry V. Flexner C. Wachsman M. The effect of systemically administered recombinant human NGF in healthy human subjects Ann Neurol 36 1994 244 246
76. Indo Y. Tsuruta M. Hayashida Y. Karim M.A. Ohta K. Kawano T. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis Nat Genet 13 1996 485 488
77. Aloe L. Skaper S.D. Leon A. Levi-Montalcini R. Nerve growth factor and autoimmune diseases Autoimmunity 19 1994 141 150
78. Falcini F. Matucci-Cerinic M. Lombardi A. Generini S. Pignone A. Tirassa P. Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis Ann Rheum Dis 55 1996 745 748
79. Dicou E. Masson C. Jabbour W. Nerriere V. Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients Neuroreport 5 1993 321 324
80. Dicou E. Perrot S. Menkes C.J. Masson C. Nerriere V. Nerve growth factor (NGF) autoantibodies and NGF in the synovial fluid: implications in spondylarthropathies Autoimmunity 24 1996 1 9
81. Dicou E. Nerriere V. Evidence that natural autoantibodies against the nerve growth factor (NGF) may be potential carriers of NGF J Neuroimmunol 75 1997 200 203
82. Aloe L. Tuveri M.A. Carcassi U. Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis Arthritis Rheum 35 1992 351 355
83. Rall L.B. Scott J. Bell G.I. Crawford R.J. Penschow J.D. Niall H.D. Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues Nature 313 1985 228 231
84. Aloe L. Alleva E. Bohm A. Levi-Montalcini R. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream Proc Nat Acad Sci U S A 83 1986 6184 6187
85. Glantz P.-O.J. Meenaghan M.A. Hyun K. Wirth S.M. On the presence and localization of epidermal and nerve growth factors in human whole saliva Acta Odontol Scand 47 1989 287 292
86. Russell I.J. Michalek J.E. Vipraio G.A. Fletcher E.M. Javors M.A. Bowden C.A. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome J Rheumatol 19 1992 104 109
87. (suppl) Russell I.J. Vipraio G.A. Serotonin (5HT) in serum and platelets (PLT) from fibromyalgia patients (FS) and normal controls (NC) Arthritis Rheum 37 1994 S214 s2
88. Wong H.Y. Neural mechanisms of joint pain Ann Acad Med Singapore 22 1993 646 650
89. (abstr) Nyberg F. Liu Z. Lind C. Thomwall M. Ordeberg G. Enhanced CSF levels of substance P in patients with painful arthrosis but not in patients with pain from herniated lumbar discs J Musculoskeletal Pain 3 suppl 1 1995 2
90. Lembeck F. Gamse R. Substance P in peripheral sensory processes Porter K. O'Connor M. Substance P in the Nervous System 1982 Pitman Books London 35 54
91. Moskowitz M.A. The neurobiology of vascular head pain Ann Neurol 16 1984 157 168
92. Martinez J.R. Martinez A.M. Stimulatory and inhibitory effects of substance P on rat submandibular secretion J Dent Res 60 1981 1031 1038
93. Lembeck F. Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation Naunyn Schmiedebergs Arch Pharmacol 310 1979 175 183
94. Nilsson J. von Fuller A.M. Dalsgaard C.J. Stimulation of connective tissue cell growth by substance P and substance K Nature 315 1985 61 63
95. Payan D.G. Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells Biochem Biophys Res Commun 130 1985 104 109
96. Boyle M.D. Lawman M.J. Gee A.P. Young M. Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo J Immunol 134 1985 564 568
97. Gilchrist W. Burkhalter E. Eaton C. Schaudies R.P. Maydonovitch C. Andrada F. The effect of indomethacin on the secretion of human salivary epidermal growth factor Am J Gastroenterol 89 1994 97 100
98. Aloe L. Bracci-Laudiero L. Alleva E. Lambiase A. Micera A. Tirassa P. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes Proc Natl Acad Sci U S A 91 1994 10440 10444
99. McGillis J.P. Mitsuhashi M. Payan D.G. Immunomodulation by tachykinin neuropeptides Ann N Y Acad Sci 594 1990 85 94
100. Payan D.G. Goetzl E.J. Modulation of lymphocyte function by sensory neuropeptides J Immunol 135 1985 7835 7865
101. Stanisz A.M. Befus D. Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytesfrom Peyer's patches, mesenteric lymph nodes and spleen J Immunol 136 1986 152 156
102. Rameshwar P. Ganea D. Gascon P. In vitro stimulatory effect of substance P on hematopoiesis Blood 81 1993 391 398
103. Asahina A. Hosoi J. Beissert S. Stratigos A. Granstein R.D. Inhibition of the induction of delayed-type and contact hypersensitivity by CGRP J Immunol 154 1995 3056 3061
104. McGillis J.P. Humphreys S. Reid S. Characterization of functional calcitonin gene-related peptide receptors on rat lymphocytes J Immunol 147 1991 3482 3489
105. Wang F. Millet I. Bottomly K. Vignery A. Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes J Biol Chem 267 1992 21052 21057
106. Wang X. Fiscus R.R. Yang L. Mathews H.L. Suppression of the functional activity of IL-2-activated lymphocytes by CGRP Cell Immunol 162 1995 105 113
107. Thorpe L.W. Perez-Polo J.R. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes J Neurosci Res 18 1987 134 139
108. Aloe L. Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor Brain Res 133 1977 358 366
109. DeSimone R. Alleva E. Tirassa P. Aloe L. Nerve growth factor released into the bloodstream following intraspecific fighting induces mast cell degranulation in adult male mice Brain Behav Immun 4 1990 74 81
110. Boyle M.D.P. Lawman M.J.P. Gee A.P. Young M. Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo J Immunol 135 1985 564 568
111. Kannan Y. Ushio H. Koyama H. Okada M. Oikawa M. Yoshiara T. Nerve growth factor enhances survival, phagocytosis and superoxide production of murine neutrophils Blood 77 1991 1320 1325
112. Scully J.L. Otten U. NGF: not just for neurons Cell Biol Int 19 1995 459 469
113. Hannestad J. Levanti M.B. Vega J.A. Distribution of neurotrophin receptors in human palatine tonsils: an immunohistochemical study J Neuroimmunol 58 1995 131 137
114. Santambrogio L. Benedetti M. Chao M.V. Muzaffar R. Kulig K. Gabellini N. Nerve growth factor production by lymphocytes J Immunol 153 1994 4488 4495
115. Arneberg P. Quantitative determination of protein in saliva: a comparison of analytical methods Scand J Dent Res 79 1971 60 64
116. (Spec. Issue) Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man J Dent Res 66 1987 648 653
117. Navazesh M. Methods of collecting Saliva Ann N Y Acad Sci 694 1993 72 77
118. Holmes J.H. Changes in salivary flow produced by changes in fluid and electrolyte balance Screebny L.M. Meyer J. Salivary Glands and Their Secretions 1964 Macmillan New York 177 195
119. Shannon I.L. Climatological effects on human parotid gland function Arch Oral Biol 11 1966 451 453
120. Dawes C. Rhythms in salivary flow rate and composition Int J Chronobiol 2 1974 253 279
121. Navazesh M. Ship J.I. Xerostomia: diagnosis and treatment Am J Otolaryngol 4 1983 283 292
122. Dawes C. Stimulus effects on protein and electrolyte concentrations in parotid saliva J Physiol (Loud) 346 1984 579 588
123. Atkinson J.C. Dawes C. Ericson T. Guidelines for saliva nomenclature and collection Ann N Y Acad Sci 694 1993 xi xii
124. Mandel I.J. The diagnostic uses of saliva J Oral Pathol Med 19 1990 119 125
125. Malamud D. Saliva as a diagnostic fluid Br Med J 305 1992 207 208
126. Mandel I.D. Salivary diagnosis: promises, promises Ann N Y Acad Sci 694 1993 2 9
127. Quissell D.O. Steroid hormone analysis in human saliva Ann N Y Acad Sci 694 1993 143 145
128. Haeckel R. Factors influencing the saliva/plasma ratio of drugs Ann N Y Acad Sci 694 1993 128 142
129. Hodel L. Grob P.J. Psyche and immunity: A selected literature study of psychoneuroimmunology in healthy persons Schweiz Med Wochenschr 123 1993 2323 2341
130. Gleeson M. Cripps A.W. Clancy R.L. Modifiers of the human mucosal immune system Immunol Cell Biol 73 1995 397 404
131. Markusse H.M. Otten H.G. Vroom T.M. Smeets T.J. Fokkens N. Breedveld F.C. Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome Clin Immunol Immunopathol 66 1993 26 32
132. van der Geest S.A. Markusse H.M. Swaak A.J. Beta 2-microglobulin measurements in saliva of patients with primary Sjögren's syndrome: influence of flow Ann Rheum Dis 52 1993 461 463
133. Maddali-Bongi S. Campana G. D'Agata A. Palermo C. Bianucci G. The diagnosis value of beta 2-microglobulin and immunoglobulins in primary Sjögren's syndrome Clin Rheumatol 14 1995 151 156
134. Barrow Z. Guiban D. Maroufi A. Fournier C. Dugue M.A. Luton J.P. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome Eur J Endocrinol 134 1996 93 96
135. Mateo L. Nolla J.M. Bonnin M.R. Navarro M.A. Roig-Escofet D. Sex hormone status and bone mineral density in men with rheumatoid arthritis J Rheumatol 22 1995 1455 1460
136. Miles V. Miranda-Massari J.R. Dupuis R.E. Mill M.R. Zaritsky A.L. Nocera M. Determination of salivary digoxin with a dry strip immunometric assay Ther Drug Monit 14 1992 249 254
137. Drobitch R.K. Svensson C.K. Therapeutic drug monitoring in saliva: an update Clin Pharmacokinet 23 1992 365 379
138. George J.R. Fitchen J.H. Future applications of oral fluid specimen technology Am J Med 202 1997 21 25
139. Albertioni F. Rask C. Schroeder H. Peterson C. Monitoring of methotrexate and 7-hydroxymethotrexate in saliva from children with acute lymphoblastic leukemia receiving high-dose consolidation treatment: relation to oral mucositis Anticancer Drugs 8 1997 119 124
140. Balcarek K.B. Warren W. Smith R.J. Lyon M.D. Pass R.E. Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva J Infect Dis 167 1993 1433 1436
141. Gautheret-Dejean A. Aubin J.T. Poirel L. Huraux J.M. Nicolas J.C. Rozenbaum W. Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocomptent subjects J Clin Microbiol 35 1997 1600 1603
142. McGuire T. Greally J. Leon J. Luka J. Epstein-Barr virus (herpesvirus 4) types A, B and herpesvirus-6 variants A and B in patients presenting with recurrent upper respiratory inflammation, persistent paravertebral thoraco-lumbar muscle spasm and fatigue by polymerase chain reaction (PCR) In Vivo 11 1997 23 28
143. Jorgensen C. Legouffe M.C. Perney P. Coste J. Tissot B. Segarra C. Sicca syndrome associated with hepatitis C virus infection Arthritis Rheum 39 1996 1166 1171
144. Malamud D. Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come Am J Med 102 1997 9 14
145. O'Farrell B.J. Rajan E. Albloushi S.S. Courtney M.G. Fielding J. Shattock A.G. The reliability of saliva as a sample for the detection of hepatitis A immunoglobulin under various sampling conditions Clin Diagn Virol 7 1997 153 157
146. Clemmons R.M. Stewart C. Davis G. Beaudreau C. Humphrey P. Browe C. Development of a prototype, rapid saliva test for hepatitis B surface antigen (HBSAg) utilizing a dipstick method Ann N Y Acad Sci 694 1993 272 273
147. Sherman K.E. Creager R.L. O'Brien J. Sargent S. Piacentini S. Thieme T. The use of oral fluid for hepatitis C antibody screening Am J Gastroenterol 89 1994 2025 2027
148. Fallone C.A. Elizov M. Cleland P. Thompson J.A. Wild G.E. Lough J. Detection of Helicobacter pylori infection by saliva IgG testing Am J Gastroenterol 91 1996 1145 1149
149. Reilly T.G. Poxon V. Sanders D.S. Elliot T.S. Walt R.P. Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests Gut 40 1997 454 458
150. Reynolds W.J. Chin B. Inman R.D. Plasma substance P levels in fibrositis J Rheumatol 15 1988 1802 1803
151. Russell I.J. Vaeroy H. Javors M. Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis Arthritis Rheum 35 1992 550 556
152. (Suppl) Houvenagel E. Forzy G. Cortet B. Vincent G. Hydroxy indolacetic acid in cerebrospinal fluid in fibromyalgia Arthritis Rheum 33 1990 S55
153. Bonafede R.P. Downey D.C. Bennett R.M. An association of fibromyalgia with primary Sjbgren's syndrome: a prospective study of 72 patients J Rheumatol 22 1995 133 136